These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 9741784)
1. The place of chemotherapy in the treatment of early breast cancer. Buzdar A Br J Cancer; 1998 Sep; 78 Suppl 4(Suppl 4):16-20. PubMed ID: 9741784 [TBL] [Abstract][Full Text] [Related]
2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Lancet; 2005 May 14-20; 365(9472):1687-717. PubMed ID: 15894097 [TBL] [Abstract][Full Text] [Related]
3. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. Goel S; Sharma R; Hamilton A; Beith J Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD004562. PubMed ID: 19821328 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. ; Castiglione-Gertsch M; O'Neill A; Price KN; Goldhirsch A; Coates AS; Colleoni M; Nasi ML; Bonetti M; Gelber RD J Natl Cancer Inst; 2003 Dec; 95(24):1833-46. PubMed ID: 14679153 [TBL] [Abstract][Full Text] [Related]
5. Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial. International Breast Cancer Study Group (IBCSG) J Natl Cancer Inst; 2002 Jul; 94(14):1054-65. PubMed ID: 12122096 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy in early breast cancer. Ejlertsen B Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018 [TBL] [Abstract][Full Text] [Related]
7. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. Sharma R; Hamilton A; Beith J Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661 [TBL] [Abstract][Full Text] [Related]
8. Complete estrogen blockade for the treatment of metastatic and early stage breast cancer. Michaud LB; Buzdar AU Drugs Aging; 2000 Apr; 16(4):261-71. PubMed ID: 10874521 [TBL] [Abstract][Full Text] [Related]
9. The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up. Castiglione-Gertsch M; Johnsen C; Goldhirsch A; Gelber RD; Rudenstam CM; Collins J; Lindtner J; Hacking A; Cortes-Funes H; Forbes J Ann Oncol; 1994 Oct; 5(8):717-24. PubMed ID: 7826904 [TBL] [Abstract][Full Text] [Related]
10. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. Crivellari D; Bonetti M; Castiglione-Gertsch M; Gelber RD; Rudenstam CM; Thürlimann B; Price KN; Coates AS; Hürny C; Bernhard J; Lindtner J; Collins J; Senn HJ; Cavalli F; Forbes J; Gudgeon A; Simoncini E; Cortes-Funes H; Veronesi A; Fey M; Goldhirsch A J Clin Oncol; 2000 Apr; 18(7):1412-22. PubMed ID: 10735888 [TBL] [Abstract][Full Text] [Related]
11. Multi-agent chemotherapy for early breast cancer. Early Breast Cancer Trialists' Collaborative Group Cochrane Database Syst Rev; 2002; (1):CD000487. PubMed ID: 11869577 [TBL] [Abstract][Full Text] [Related]
12. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet; 1998 Sep; 352(9132):930-42. PubMed ID: 9752815 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients. International Breast Cancer Study Group J Clin Oncol; 1997 Apr; 15(4):1385-94. PubMed ID: 9193330 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279 [TBL] [Abstract][Full Text] [Related]
15. A systematic overview of chemotherapy effects in breast cancer. Bergh J; Jönsson PE; Glimelius B; Nygren P; Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936 [TBL] [Abstract][Full Text] [Related]
16. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801 [TBL] [Abstract][Full Text] [Related]
17. Direct comparisons of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer patients stratified by estrogen receptor and menopausal status. Nomura Y; Shirouzu M; Takayama T Breast Cancer Res Treat; 1998 May; 49(1):51-60. PubMed ID: 9694611 [TBL] [Abstract][Full Text] [Related]
18. Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer. Karlsson P; Sun Z; Braun D; Price KN; Castiglione-Gertsch M; Rabaglio M; Gelber RD; Crivellari D; Collins J; Murray E; Zaman K; Colleoni M; Gusterson BA; Viale G; Regan MM; Coates AS; Goldhirsch A Ann Oncol; 2011 Oct; 22(10):2216-26. PubMed ID: 21325445 [TBL] [Abstract][Full Text] [Related]
19. Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations. Pritchard KI Oncology (Williston Park); 2009 Jan; 23(1):27-33. PubMed ID: 19283918 [TBL] [Abstract][Full Text] [Related]
20. Tamoxifen for early breast cancer. Early Breast Cancer Trialists' Collaborative Group Cochrane Database Syst Rev; 2001; (1):CD000486. PubMed ID: 11279694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]